Literature DB >> 10587213

A mathematical model of motion of the heart for use in generating source and attenuation maps for simulating emission imaging.

P H Pretorius1, M A King, B M Tsui, K J LaCroix, W Xia.   

Abstract

This manuscript documents the alteration of the heart model of the three-dimensional (3D) mathematical cardiac torso (MCAT) phantom to represent cardiac motion. The objective of the inclusion of motion was to develop a digital simulation of the heart such that the impact of cardiac motion on single-photon emission computed tomography (SPECT) imaging could be assessed and methods of quantitating cardiac function could be investigated. The motion of the gated 3D MCAT's (gMCAT) heart is modeled using 128 separate and evenly spaced time samples from a blood volume curve approximating an average heart cycle. Sets of adjacent time samples can be grouped together to represent a single time interval within the heart cycle. Maximum and minimum chamber volumes were selected to be similar to those of a normal healthy person while the total heart volume stayed constant during the cardiac cycle. Myocardial mass was conserved during the cardiac cycle and the bases of the ventricles were modeled as moving towards the static apex. The orientation of the 3D MCAT heart was changed during contraction to rotate back and forth around the long axis through the center of the left ventricle (LV) using the end systolic time interval as the time point at which to reverse direction. Simple respiratory motion was also introduced by changing the orientation of the long axis of the heart to represent its variation with respiration. Heart models for 24 such orientations spanning the range of motion during the respiratory cycle were averaged together for each time sample to represent the blurring of the heart during the acquisition of multiple cardiac cycles. Finally, an option to model apical thinning of the myocardium was included. As an illustration of the application of the gMCAT phantom, the gated heart model was evaluated by measuring myocardial wall thickening. A linear relationship was obtained between maximum myocardial counts and myocardial thickness, similar to published results. Similar results were obtained for full width at half maximum (FWHM) measurements. With the presence of apical thinning, an apparent increase in counts in the apical region compared to the other heart walls in the absence of attenuation compensation turns into an apparent decrease in counts with attenuation compensation. The apical decrease was more prominent in end systole (ES) than end diastole (ED) due to the change in the partial volume effect. These observations agree with clinical trends. It is concluded that the gMCAT phantom can be used to study the influence of various physical parameters on radionuclide perfusion imaging.

Entities:  

Mesh:

Year:  1999        PMID: 10587213     DOI: 10.1118/1.598746

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  27 in total

1.  Clinical significance of apical thinning after attenuation correction.

Authors:  Jonathan M Links; Lewis C Becker; Frank Anstett
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

2.  A realistic 3-D gated cardiac phantom for quality control of gated myocardial perfusion SPET: the Amsterdam gated (AGATE) cardiac phantom.

Authors:  Jacco J N Visser; Ellinor Busemann Sokole; Hein J Verberne; Jan B A Habraken; Huybert J F van de Stadt; Joris E N Jaspers; Morgan Shehata; Paul M Heeman; Berthe L F van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

Review 3.  Dynamic single photon emission computed tomography--basic principles and cardiac applications.

Authors:  Grant T Gullberg; Bryan W Reutter; Arkadiusz Sitek; Jonathan S Maltz; Thomas F Budinger
Journal:  Phys Med Biol       Date:  2010-09-22       Impact factor: 3.609

4.  Image denoising methods for tumor discrimination in high-resolution computed tomography.

Authors:  José Silvestre Silva; Augusto Silva; Beatriz Sousa Santos
Journal:  J Digit Imaging       Date:  2011-06       Impact factor: 4.056

5.  Adaptation and applications of a realistic digital phantom based on patient lung tumor trajectories.

Authors:  Pankaj Mishra; Sara St James; W Paul Segars; Ross I Berbeco; John H Lewis
Journal:  Phys Med Biol       Date:  2012-06-07       Impact factor: 3.609

6.  Simultaneous assessment of cardiac perfusion and function using 5-dimensional imaging with Tc-99m teboroxime.

Authors:  Bing Feng; P Hendrik Pretorius; Troy H Farncombe; Seth T Dahlberg; Manoj V Narayanan; Miles N Wernick; Anna M Celler; Jeffrey A Leppo; Michael A King
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

7.  Use of three-dimensional Gaussian interpolation in the projector/backprojector pair of iterative reconstruction for compensation of known rigid-body motion in SPECT.

Authors:  Bing Feng; Howard C Gifford; Richard D Beach; Guido Boening; Michael A Gennert; Michael A King
Journal:  IEEE Trans Med Imaging       Date:  2006-07       Impact factor: 10.048

8.  Alignment of 3-dimensional cardiac structures in O-15-labeled water PET emission images with mutual information.

Authors:  Anu Juslin; Jyrki Lötjönen; Sergey V Nesterov; Kari Kalliokoski; Juhani Knuuti; Ulla Ruotsalainen
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

9.  Estimation of the Rigid-Body Motion from Three-Dimensional Images Using a Generalized Center-of-Mass Points Approach.

Authors:  B Feng; P P Bruyant; P H Pretorius; R D Beach; H C Gifford; J Dey; M Gennert; M A King
Journal:  IEEE Trans Nucl Sci       Date:  2006-10       Impact factor: 1.679

10.  An evaluation of iterative reconstruction strategies based on mediastinal lesion detection using hybrid Ga-67 SPECT images.

Authors:  Nicholas F Pereira; Howard C Gifford; P Hendrik Pretorius; Mark Smyczynski; Robert Licho; Peter Schneider; Troy Farncombe; Michael A King
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.